The current valuation score of Vertex Pharmaceuticals Inc is 7.79, ranking 119 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is 32.12, which is 5.70% below the recent high of 33.95 and 968.19% above the recent low of -278.85.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.